These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1096 related items for PubMed ID: 3754580

  • 1. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. I. Characterization and regulation of agonist binding to putative muscarinic subtypes.
    Watson M, Yamamura HI, Roeske WR.
    J Pharmacol Exp Ther; 1986 May; 237(2):411-8. PubMed ID: 3754580
    [Abstract] [Full Text] [Related]

  • 2. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes.
    Watson M, Roeske WR, Yamamura HI.
    J Pharmacol Exp Ther; 1986 May; 237(2):419-27. PubMed ID: 3754581
    [Abstract] [Full Text] [Related]

  • 3. Characterization of [3H]pirenzepine binding to muscarinic cholinergic receptors solubilized from rat brain.
    Luthin GR, Wolfe BB.
    J Pharmacol Exp Ther; 1985 Jul; 234(1):37-44. PubMed ID: 3839265
    [Abstract] [Full Text] [Related]

  • 4. Comparison of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to muscarinic cholinergic receptors in rat brain.
    Luthin GR, Wolfe BB.
    J Pharmacol Exp Ther; 1984 Mar; 228(3):648-55. PubMed ID: 6546770
    [Abstract] [Full Text] [Related]

  • 5. Differential ontogeny of putative M1 and M2 muscarinic receptor binding sites in the murine cerebral cortex and heart.
    Evans RA, Watson M, Yamamura HI, Roeske WR.
    J Pharmacol Exp Ther; 1985 Dec; 235(3):612-8. PubMed ID: 3841156
    [Abstract] [Full Text] [Related]

  • 6. Characterization of high affinity [3H]pirenzepine and (-)-[3H] quinuclidinyl benzilate binding to muscarinic cholinergic receptors in rabbit peripheral lung.
    Bloom JW, Halonen M, Lawrence LJ, Rould E, Seaver NA, Yamamura HI.
    J Pharmacol Exp Ther; 1987 Jan; 240(1):51-8. PubMed ID: 3806397
    [Abstract] [Full Text] [Related]

  • 7. Pharmacological differences between the high-affinity muscarinic agonist binding states of the rat heart and cerebral cortex labeled with (+)-[3H]cismethyldioxolane.
    Vickroy TW, Roeske WR, Yamamura HI.
    J Pharmacol Exp Ther; 1984 Jun; 229(3):747-55. PubMed ID: 6202869
    [Abstract] [Full Text] [Related]

  • 8. Muscarinic cholinergic receptor binding sites differentiated by their affinity for pirenzepine do not interconvert.
    Gil DW, Wolfe BB.
    J Pharmacol Exp Ther; 1986 May; 237(2):577-82. PubMed ID: 3009794
    [Abstract] [Full Text] [Related]

  • 9. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes.
    Burke RE.
    Mol Pharmacol; 1986 Jul; 30(1):58-68. PubMed ID: 3755217
    [Abstract] [Full Text] [Related]

  • 10. Solubilization with digitonin alters the kinetics of pirenzepine binding to muscarinic receptors from rat forebrain and heart.
    Wang JX, Mei L, Yamamura HI, Roeske WR.
    J Pharmacol Exp Ther; 1987 Sep; 242(3):981-90. PubMed ID: 3116203
    [Abstract] [Full Text] [Related]

  • 11. Cholinergic innervation and topographical organization of muscarinic binding sites in rat brain: a comparative autoradiographic study.
    Tonnaer JA, Ernste BH, Wester J, Kelder K.
    J Chem Neuroanat; 1988 Sep; 1(2):95-110. PubMed ID: 3267343
    [Abstract] [Full Text] [Related]

  • 12. [3H]Pirenzepine and [3H]quinuclidinyl benzilate binding to brain muscarinic cholinergic receptors. Differences in measured receptor density are not explained by differences in receptor isomerization.
    Luthin GR, Wolfe BB.
    Mol Pharmacol; 1984 Sep; 26(2):164-9. PubMed ID: 6548291
    [Abstract] [Full Text] [Related]

  • 13. Regulation of muscarinic receptor subtypes and their responsiveness in rat brain following chronic atropine administration.
    Lee W, Wolfe BB.
    Mol Pharmacol; 1989 Nov; 36(5):749-57. PubMed ID: 2555673
    [Abstract] [Full Text] [Related]

  • 14. Antibodies to a synthetic peptide can be used to distinguish between muscarinic acetylcholine receptor binding sites in brain and heart.
    Luthin GR, Harkness J, Artymyshyn RP, Wolfe BB.
    Mol Pharmacol; 1988 Sep; 34(3):327-33. PubMed ID: 3419425
    [Abstract] [Full Text] [Related]

  • 15. Characterization of muscarinic cholinergic receptor subtypes in human peripheral lung.
    Bloom JW, Halonen M, Yamamura HI.
    J Pharmacol Exp Ther; 1988 Feb; 244(2):625-32. PubMed ID: 3346839
    [Abstract] [Full Text] [Related]

  • 16. A unique regulatory profile and regional distribution of [3H]pirenzepine binding in the rat provide evidence for distinct M1 and M2 muscarinic receptor subtypes.
    Watson M, Yamamura HI, Roeske WR.
    Life Sci; 1983 Jun 27; 32(26):3001-11. PubMed ID: 6688111
    [Abstract] [Full Text] [Related]

  • 17. Differential interactions of muscarinic drugs with binding sites of [3H]pirenzepine and [3H]quinuclidinyl benzilate in rat brain tissue.
    Tonnaer JA, van Vugt MA, de Boer T, de Graaf JS.
    Life Sci; 1987 May 18; 40(20):1981-7. PubMed ID: 3573989
    [Abstract] [Full Text] [Related]

  • 18. Differential effects of alkylating agents on the multiple muscarinic receptor subtypes linked to activation of phospholipase C by carbachol in rat brain cortical membranes.
    Sallés J, Wallace MA, Fain JN.
    J Pharmacol Exp Ther; 1993 Feb 18; 264(2):521-9. PubMed ID: 8437104
    [Abstract] [Full Text] [Related]

  • 19. Characterization of agonist and antagonist binding to muscarinic cholinergic receptors solubilized from rat cerebral cortex.
    Adem A, Sabbagh M, Nordberg A.
    J Neural Transm; 1988 Feb 18; 72(1):11-8. PubMed ID: 3379385
    [Abstract] [Full Text] [Related]

  • 20. Multiple in vitro interactions with and differential in vivo regulation of muscarinic receptor subtypes by tetrahydroaminoacridine.
    Flynn DD, Mash DC.
    J Pharmacol Exp Ther; 1989 Aug 18; 250(2):573-81. PubMed ID: 2760841
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 55.